2-CHLOROBENZYLAMINE, 97% (GC)

SECTION 2: Hazards identification

EMERGENCY OVERVIEW Appearance: clear yellow liquid. Flash Point: 88 deg C. Danger! Corrosive. Causes eye and skin burns. Combustible liquid and vapor. May cause severe respiratory tract irritation with possible burns. May cause severe digestive tract irritation with possible burns. May cause central nervous system depression. May cause cardiac disturbances. May cause liver and kidney damage. May cause methemoglobinemia. Air sensitive. Target Organs: TM TM Blood, kidneys, central nervous system, liver, cardiovascular system, blood forming organs.

Potential health effects

Eye: Causes eye burns. May cause chemical conjunctivitis and corneal damage. Skin: Causes skin burns. May cause cyanosis of the extremities. May cause skin rash (in milder cases), and cold and clammy skin with cyanosis or pale color. TM TM 1 Ingestion: Causes gastrointestinal tract burns. May cause liver and kidney damage. May cause perforation of the digestive tract. May cause cardiac disturbances. May cause methemoglobinemia, cyanosis (bluish discoloration of skin due to deficient oxygenation of the blood), convulsions, and death. May cause central nervous system depression. May cause systemic effects. Inhalation: May cause methemoglobinemia, cyanosis (bluish discoloration of skin due to deficient oxygenation of the blood), convulsions, tachycardia, dyspnea (labored breathing), and death. May cause liver and kidney damage. Causes chemical burns to the respiratory tract. Aspiration may lead to pulmonary edema. May cause cardiac abnormalities. May cause systemic effects. Inhalation at high concentrations may cause CNS depression and asphixiation. Chronic: May cause liver and kidney damage. May cause methemoglobinemia, which is characterized by chocolate-brown colored blood, headache, weakness, dizziness, breath shortness, cyanosis (bluish skin due to deficient oxygenation of blood), rapid heart rate, unconsciousness and possible death. Effects may be delayed. -------------------------------------------------------------------------------------------------------